Preoperative prognostic nutritional index and systemic immune‐inflammation index predict survival outcomes in osteosarcoma: A comparison between young and elderly patients
Objective This retrospective study of patients with osteosarcoma investigated the following biomarkers of inflammation and nutritional status: neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio, prognostic nutritional index (PNI), and systemic immune‐inflammation index (SII). The efficacie...
Saved in:
Published in | Journal of surgical oncology Vol. 125; no. 4; pp. 754 - 765 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.03.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective
This retrospective study of patients with osteosarcoma investigated the following biomarkers of inflammation and nutritional status: neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio, prognostic nutritional index (PNI), and systemic immune‐inflammation index (SII). The efficacies of these indicators to predict overall survival (OS) of young and elderly patients were compared.
Methods
The data of 125 patients with osteosarcoma, comprising the young (≤20 years) and elderly (60–80 years), were reviewed. Receiver operating characteristic (ROC) curves were calculated to determine the optimal cut‐off value and area under the ROC curve of each potential biomarker. Kaplan–Meier curves and a Cox proportional hazards model were used to perform survival analyses.
Results
The cut‐off values for low and high PNI ( ≤48.5, >48.5) and low and high SII (≤607.3, >607.3) were determined. Osteosarcoma patients in low PNI group or high SII group exhibited poorer OS relative to those in high PNI or low SII groups. The univariate and multivariate analyses indicated that preoperative PNI and SII were independent prognostic factors for OS in both the young and elderly subjects.
Conclusion
Preoperative PNI and SII can be viable biomarkers of prognosis for both young and elderly patients with osteosarcoma. Awareness of these valuable indexes will enable clinicians to evaluate the inflammatory and nutritional status of these patients and establish a framework for individualized therapy. |
---|---|
AbstractList | This retrospective study of patients with osteosarcoma investigated the following biomarkers of inflammation and nutritional status: neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, prognostic nutritional index (PNI), and systemic immune-inflammation index (SII). The efficacies of these indicators to predict overall survival (OS) of young and elderly patients were compared.OBJECTIVEThis retrospective study of patients with osteosarcoma investigated the following biomarkers of inflammation and nutritional status: neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, prognostic nutritional index (PNI), and systemic immune-inflammation index (SII). The efficacies of these indicators to predict overall survival (OS) of young and elderly patients were compared.The data of 125 patients with osteosarcoma, comprising the young (≤20 years) and elderly (60-80 years), were reviewed. Receiver operating characteristic (ROC) curves were calculated to determine the optimal cut-off value and area under the ROC curve of each potential biomarker. Kaplan-Meier curves and a Cox proportional hazards model were used to perform survival analyses.METHODSThe data of 125 patients with osteosarcoma, comprising the young (≤20 years) and elderly (60-80 years), were reviewed. Receiver operating characteristic (ROC) curves were calculated to determine the optimal cut-off value and area under the ROC curve of each potential biomarker. Kaplan-Meier curves and a Cox proportional hazards model were used to perform survival analyses.The cut-off values for low and high PNI ( ≤48.5, >48.5) and low and high SII (≤607.3, >607.3) were determined. Osteosarcoma patients in low PNI group or high SII group exhibited poorer OS relative to those in high PNI or low SII groups. The univariate and multivariate analyses indicated that preoperative PNI and SII were independent prognostic factors for OS in both the young and elderly subjects.RESULTSThe cut-off values for low and high PNI ( ≤48.5, >48.5) and low and high SII (≤607.3, >607.3) were determined. Osteosarcoma patients in low PNI group or high SII group exhibited poorer OS relative to those in high PNI or low SII groups. The univariate and multivariate analyses indicated that preoperative PNI and SII were independent prognostic factors for OS in both the young and elderly subjects.Preoperative PNI and SII can be viable biomarkers of prognosis for both young and elderly patients with osteosarcoma. Awareness of these valuable indexes will enable clinicians to evaluate the inflammatory and nutritional status of these patients and establish a framework for individualized therapy.CONCLUSIONPreoperative PNI and SII can be viable biomarkers of prognosis for both young and elderly patients with osteosarcoma. Awareness of these valuable indexes will enable clinicians to evaluate the inflammatory and nutritional status of these patients and establish a framework for individualized therapy. Objective This retrospective study of patients with osteosarcoma investigated the following biomarkers of inflammation and nutritional status: neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio, prognostic nutritional index (PNI), and systemic immune‐inflammation index (SII). The efficacies of these indicators to predict overall survival (OS) of young and elderly patients were compared. Methods The data of 125 patients with osteosarcoma, comprising the young (≤20 years) and elderly (60–80 years), were reviewed. Receiver operating characteristic (ROC) curves were calculated to determine the optimal cut‐off value and area under the ROC curve of each potential biomarker. Kaplan–Meier curves and a Cox proportional hazards model were used to perform survival analyses. Results The cut‐off values for low and high PNI ( ≤48.5, >48.5) and low and high SII (≤607.3, >607.3) were determined. Osteosarcoma patients in low PNI group or high SII group exhibited poorer OS relative to those in high PNI or low SII groups. The univariate and multivariate analyses indicated that preoperative PNI and SII were independent prognostic factors for OS in both the young and elderly subjects. Conclusion Preoperative PNI and SII can be viable biomarkers of prognosis for both young and elderly patients with osteosarcoma. Awareness of these valuable indexes will enable clinicians to evaluate the inflammatory and nutritional status of these patients and establish a framework for individualized therapy. This retrospective study of patients with osteosarcoma investigated the following biomarkers of inflammation and nutritional status: neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, prognostic nutritional index (PNI), and systemic immune-inflammation index (SII). The efficacies of these indicators to predict overall survival (OS) of young and elderly patients were compared. The data of 125 patients with osteosarcoma, comprising the young (≤20 years) and elderly (60-80 years), were reviewed. Receiver operating characteristic (ROC) curves were calculated to determine the optimal cut-off value and area under the ROC curve of each potential biomarker. Kaplan-Meier curves and a Cox proportional hazards model were used to perform survival analyses. The cut-off values for low and high PNI ( ≤48.5, >48.5) and low and high SII (≤607.3, >607.3) were determined. Osteosarcoma patients in low PNI group or high SII group exhibited poorer OS relative to those in high PNI or low SII groups. The univariate and multivariate analyses indicated that preoperative PNI and SII were independent prognostic factors for OS in both the young and elderly subjects. Preoperative PNI and SII can be viable biomarkers of prognosis for both young and elderly patients with osteosarcoma. Awareness of these valuable indexes will enable clinicians to evaluate the inflammatory and nutritional status of these patients and establish a framework for individualized therapy. ObjectiveThis retrospective study of patients with osteosarcoma investigated the following biomarkers of inflammation and nutritional status: neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio, prognostic nutritional index (PNI), and systemic immune‐inflammation index (SII). The efficacies of these indicators to predict overall survival (OS) of young and elderly patients were compared.MethodsThe data of 125 patients with osteosarcoma, comprising the young (≤20 years) and elderly (60–80 years), were reviewed. Receiver operating characteristic (ROC) curves were calculated to determine the optimal cut‐off value and area under the ROC curve of each potential biomarker. Kaplan–Meier curves and a Cox proportional hazards model were used to perform survival analyses.ResultsThe cut‐off values for low and high PNI ( ≤48.5, >48.5) and low and high SII (≤607.3, >607.3) were determined. Osteosarcoma patients in low PNI group or high SII group exhibited poorer OS relative to those in high PNI or low SII groups. The univariate and multivariate analyses indicated that preoperative PNI and SII were independent prognostic factors for OS in both the young and elderly subjects.ConclusionPreoperative PNI and SII can be viable biomarkers of prognosis for both young and elderly patients with osteosarcoma. Awareness of these valuable indexes will enable clinicians to evaluate the inflammatory and nutritional status of these patients and establish a framework for individualized therapy. |
Author | Guo, Jingjing Ma, Cong Li, Junhong Yu, Ronghui Wang, Xiaoyan Liu, Ping Xu, Jianyun |
Author_xml | – sequence: 1 givenname: Cong surname: Ma fullname: Ma, Cong organization: Huazhong University of Science and Technology – sequence: 2 givenname: Ronghui surname: Yu fullname: Yu, Ronghui organization: First Affiliated Hospital of Nanchang University – sequence: 3 givenname: Junhong surname: Li fullname: Li, Junhong organization: Huazhong University of Science and Technology – sequence: 4 givenname: Jingjing surname: Guo fullname: Guo, Jingjing organization: Huazhong University of Science and Technology – sequence: 5 givenname: Jianyun surname: Xu fullname: Xu, Jianyun organization: First Affiliated Hospital of Nanchang University – sequence: 6 givenname: Xiaoyan surname: Wang fullname: Wang, Xiaoyan organization: First Affiliated Hospital of Nanchang University – sequence: 7 givenname: Ping orcidid: 0000-0002-1091-8566 surname: Liu fullname: Liu, Ping email: tongji71mc@163.com organization: Huazhong University of Science and Technology |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34811745$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1u1TAQhS1URG8LC14AWWJDF2n9F8dhV1X8qlKRgHXkOJPKV4kdbOeW7HgEXqQvxZPg-wOLSrAaac53zkhzTtCR8w4Qek7JOSWEXayjP2eyKqtHaEVJLYua1OoIrbLGClHV5BidxLgmhNS1FE_QMReK0kqUK3T_KYCfIOhkN4Cn4G-dj8ka7OYUbLLe6QFb18F3rF2H4xITjFm24zg7-PXjp3X9oMdRb9EDOAXorEk4zmFjN9nv52T8CDHrOKeDjzrkhX6NL3Gekw42ZncL6Q7A4cXP7nZ3DoYOwrDgKceDS_EpetzrIcKzwzxFX9---XL1vri-effh6vK6MLzkVcGEaKU2Vc87xhRXTFNBuWyrngEnrCuVlB1rS6l7SnrFQFIpqDCaKw7SKH6KXu1z80O-zRBTM9poYBi0Az_HhklChSpZVWf05QN07eeQv7almFRMyopn6sWBmtsRumYKdtRhaf4UkYGzPWCCjzFA_xehpNmW3OSSm13Jmb14wBqbdgWkoO3wP8edHWD5d3Tz8fPN3vEbUUG9Qw |
CitedBy_id | crossref_primary_10_3389_fimmu_2024_1416068 crossref_primary_10_1016_j_joms_2024_05_001 crossref_primary_10_1002_ppul_25926 crossref_primary_10_3390_onco4020009 crossref_primary_10_1111_jcmm_18286 crossref_primary_10_1186_s13048_025_01631_4 crossref_primary_10_1016_j_phymed_2025_156464 crossref_primary_10_1007_s44231_022_00020_5 crossref_primary_10_1002_jor_25757 crossref_primary_10_1097_MD_0000000000034926 crossref_primary_10_1016_j_jbo_2023_100472 crossref_primary_10_62347_MHXS8480 crossref_primary_10_1007_s00520_022_07286_x crossref_primary_10_3390_cancers15041080 |
Cites_doi | 10.1007/s00264-019-04332-y 10.1038/nrendo.2017.16 10.1016/j.ejon.2005.09.007 10.1007/s11605-020-04710-7 10.1016/j.ygyno.2018.11.034 10.1111/j.1538-7836.2010.04131.x 10.1016/j.cell.2010.01.025 10.1002/jcp.27052 10.1093/annonc/mdy310 10.1038/nri3174 10.1016/j.lungcan.2017.07.024 10.1097/MCO.0b013e32832a7902 10.1111/crj.12925 10.1146/annurev-nutr-121415-112634 10.1111/j.0894-0959.2004.17603.x 10.1158/2326-6066.CIR-15-0313 10.1186/s12967-018-1638-9 10.1007/s10552-015-0607-3 10.1016/j.ejso.2016.04.056 10.1038/nrclinonc.2012.209 10.1007/s00408-020-00333-6 10.1200/JCO.19.00827 10.1016/j.ejso.2019.10.024 10.1038/nrc3611 10.1007/s10555-017-9673-1 10.1200/JCO.2017.75.1743 10.1038/nrclinonc.2016.24 10.1245/s10434-013-3210-4 10.1186/s10195-020-00552-w 10.1016/S1470-2045(14)70263-3 10.1016/j.jss.2014.07.037 10.21037/apm.2020.04.31 10.1097/SLA.0000000000002985 10.1038/sj.bjp.0706013 10.1200/JCO.2014.59.4895 10.1093/carcin/bgs123 10.1016/j.lungcan.2017.07.003 10.1186/s13045-018-0669-2 10.1002/jcp.28476 |
ContentType | Journal Article |
Copyright | 2021 Wiley Periodicals LLC 2021 Wiley Periodicals LLC. 2022 Wiley Periodicals LLC |
Copyright_xml | – notice: 2021 Wiley Periodicals LLC – notice: 2021 Wiley Periodicals LLC. – notice: 2022 Wiley Periodicals LLC |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
DOI | 10.1002/jso.26757 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1096-9098 |
EndPage | 765 |
ExternalDocumentID | 34811745 10_1002_jso_26757 JSO26757 |
Genre | article Journal Article Comparative Study |
GroupedDBID | --- .3N .GA 05W 0R~ 10A 1L6 1OB 1OC 1ZS 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AAXRX AAYCA AAZKR ABCQN ABCUV ABIJN ABJNI ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EMOBN F00 F01 F04 F5P FUBAC G-S G.N GNP GODZA H.X HBH HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 QRW R.K ROL RWI RX1 RYL SUPJJ SV3 TEORI UB1 V2E V8K W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WWO WXI WXSBR XG1 XPP XV2 ZZTAW ~IA ~WT .55 .GJ .Y3 31~ 3O- 53G AANHP AAQQT AASGY AAYXX ABEML ACBWZ ACRPL ACSCC ACYXJ ADNMO AEYWJ AFFNX AGHNM AGQPQ AGYGG ASPBG AVWKF AZFZN BDRZF CITATION EJD FEDTE GLUZI HF~ HVGLF LW6 M6P PALCI RIWAO RJQFR SAMSI X7M ZGI ZXP CGR CUY CVF ECM EIF NPM AAMMB AEFGJ AGXDD AIDQK AIDYY K9. 7X8 |
ID | FETCH-LOGICAL-c3537-244b6ac7f3d228382a14136b7f2e302d5866d2b56af10f82e616414ca383e6c83 |
IEDL.DBID | DR2 |
ISSN | 0022-4790 1096-9098 |
IngestDate | Fri Jul 11 16:45:16 EDT 2025 Mon Jul 14 21:15:20 EDT 2025 Wed Feb 19 02:26:48 EST 2025 Thu Apr 24 22:57:22 EDT 2025 Tue Jul 01 03:19:07 EDT 2025 Wed Jan 22 16:27:35 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | systemic immune-inflammation index prognostic nutritional index young and elderly prognosis osteosarcoma |
Language | English |
License | 2021 Wiley Periodicals LLC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3537-244b6ac7f3d228382a14136b7f2e302d5866d2b56af10f82e616414ca383e6c83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
ORCID | 0000-0002-1091-8566 |
PMID | 34811745 |
PQID | 2626826673 |
PQPubID | 1016364 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_2601485279 proquest_journals_2626826673 pubmed_primary_34811745 crossref_primary_10_1002_jso_26757 crossref_citationtrail_10_1002_jso_26757 wiley_primary_10_1002_jso_26757_JSO26757 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-03-01 |
PublicationDateYYYYMMDD | 2022-03-01 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Journal of surgical oncology |
PublicationTitleAlternate | J Surg Oncol |
PublicationYear | 2022 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2021; 25 2018; 29 2004; 143 2015; 33 2020; 38 2010; 140 2017; 111 2012; 12 2012; 33 2016; 36 2016; 13 2014; 21 2011; 9 2009; 12 2016; 4 2015; 26 2015; 193 2014; 5 2013; 10 2017; 36 2013; 13 2019; 43 2020; 198 2004; 17 2005; 9 2017; 13 2020; 271 2020; 9 2016; 42 2014; 15 2019; 234 2020; 46 2020; 21 2018; 12 2019; 152 2018; 11 2018; 16 2018; 36 e_1_2_11_10_1 e_1_2_11_32_1 e_1_2_11_31_1 e_1_2_11_36_1 e_1_2_11_14_1 e_1_2_11_13_1 Gros A (e_1_2_11_30_1) 2014; 5 e_1_2_11_35_1 e_1_2_11_12_1 e_1_2_11_34_1 e_1_2_11_11_1 e_1_2_11_33_1 e_1_2_11_7_1 e_1_2_11_29_1 e_1_2_11_6_1 e_1_2_11_28_1 e_1_2_11_5_1 e_1_2_11_27_1 e_1_2_11_4_1 e_1_2_11_26_1 e_1_2_11_3_1 e_1_2_11_2_1 e_1_2_11_21_1 e_1_2_11_20_1 e_1_2_11_25_1 e_1_2_11_40_1 e_1_2_11_24_1 e_1_2_11_41_1 e_1_2_11_9_1 e_1_2_11_23_1 e_1_2_11_8_1 e_1_2_11_22_1 e_1_2_11_18_1 e_1_2_11_17_1 e_1_2_11_16_1 e_1_2_11_15_1 e_1_2_11_37_1 e_1_2_11_38_1 e_1_2_11_39_1 e_1_2_11_19_1 |
References_xml | – volume: 46 start-page: 620 issue: 4 Pt A year: 2020 end-page: 625 article-title: Prognostic significance of body mass index and prognostic nutritional index in stage II/III gastric cancer publication-title: Eur J Surg Oncol – volume: 36 start-page: 249 issue: 2 year: 2017 end-page: 262 article-title: Platelets and cancer angiogenesis nexus publication-title: Cancer Metastasis Rev – volume: 11 start-page: 125 issue: 1 year: 2018 article-title: Role of platelets and platelet receptors in cancer metastasis publication-title: J Hematol Oncol – volume: 13 start-page: 480 issue: 8 year: 2017 end-page: 491 article-title: Germline and somatic genetics of osteosarcoma—connecting aetiology, biology and therapy publication-title: Nat Rev Endocrinol – volume: 42 start-page: 1103 issue: 8 year: 2016 end-page: 1114 article-title: Positron emission tomography (18)F‐fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: a meta‐analysis publication-title: Eur J Surg Oncol – volume: 15 start-page: e493 issue: 11 year: 2014 end-page: e503 article-title: Cancer‐related inflammation and treatment effectiveness publication-title: Lancet Oncol – volume: 234 start-page: 18408 issue: 10 year: 2019 end-page: 18414 article-title: Prognostic value of prognostic nutritional index and systemic immune‐inflammation index in patients with osteosarcoma publication-title: J Cell Physiol – volume: 10 start-page: 90 issue: 2 year: 2013 end-page: 99 article-title: Understanding the mechanisms and treatment options in cancer cachexia publication-title: Nat Rev Clin Oncol – volume: 36 start-page: 665 year: 2016 end-page: 681 article-title: Diet, nutrition, and cancer epigenetics publication-title: Annu Rev Nutr – volume: 5 start-page: 678 year: 2014 article-title: Platelets in inflammation: regulation of leukocyte activities and vascular repair publication-title: Front Immunol – volume: 234 start-page: 1794 issue: 2 year: 2019 end-page: 1802 article-title: The predictive value of a preoperative systemic immune‐inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma publication-title: J Cell Physiol – volume: 36 start-page: 188 issue: 2 year: 2018 end-page: 193 article-title: Osteosarcoma, chondrosarcoma, and chordoma publication-title: J Clin Oncol – volume: 111 start-page: 176 year: 2017 end-page: 181 article-title: Neutrophil‐to‐lymphocyte ratio (NLR) and platelet‐to‐lymphocyte ratio (PLR) as prognostic markers in patients with non‐small cell lung cancer (NSCLC) treated with nivolumab publication-title: Lung Cancer – volume: 9 start-page: 967 issue: 3 year: 2020 end-page: 978 article-title: The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non‐small cell lung cancer treated with platinum‐based chemotherapeutics publication-title: Ann Palliat Med – volume: 12 start-page: 2433 issue: 9 year: 2018 end-page: 2440 article-title: Clinical impact of pretreatment prognostic nutritional index (PNI) in small cell lung cancer patients treated with platinum‐based chemotherapy publication-title: Clin Respir J – volume: 111 start-page: 88 year: 2017 end-page: 95 article-title: Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non‐small cell lung cancer: comparative study of normal lung, emphysema, and pulmonary fibrosis publication-title: Lung Cancer – volume: 12 start-page: 239 issue: 4 year: 2012 end-page: 252 article-title: Targeting natural killer cells and natural killer T cells in cancer publication-title: Nat Rev Immunol – volume: 12 start-page: 223 issue: 3 year: 2009 end-page: 226 article-title: Systemic inflammation, nutritional status and survival in patients with cancer publication-title: Curr Opin Clin Nutr Metab Care – volume: 38 start-page: 823 issue: 8 year: 2020 end-page: 833 article-title: Pathological fracture and prognosis of high‐grade osteosarcoma of the extremities: an analysis of 2,847 consecutive cooperative osteosarcoma Study Group (COSS) patients publication-title: J Clin Oncol – volume: 26 start-page: 1127 issue: 8 year: 2015 end-page: 1139 article-title: Bone cancer incidence by morphological subtype: a global assessment publication-title: Cancer Causes Control – volume: 16 start-page: 273 issue: 1 year: 2018 article-title: The systemic immune‐inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor publication-title: J Transl Med – volume: 143 start-page: 819 issue: 7 year: 2004 end-page: 826 article-title: Platelet—cancer interactions: mechanisms and pharmacology of tumour cell‐induced platelet aggregation publication-title: Br J Pharmacol – volume: 25 start-page: 1124 issue: 5 year: 2021 end-page: 1133 article-title: Systemic immune‐inflammation index predicts overall survival in patients with gastric cancer: a propensity score‐matched analysis publication-title: J Gastrointest Surg – volume: 21 start-page: 13 issue: 1 year: 2020 article-title: Definitive surgery of primary lesion should be prioritized over preoperative chemotherapy to treat high‐grade osteosarcoma in patients aged 41‐65 years publication-title: J Orthop Traumatol – volume: 13 start-page: 504 issue: 8 year: 2016 end-page: 515 article-title: nutrition, and cancer: past publication-title: Nat Rev Clin Oncol – volume: 21 start-page: 263 issue: 1 year: 2014 end-page: 268 article-title: Prognostic factors in elderly osteosarcoma patients: a multi‐institutional retrospective study of 86 cases publication-title: Ann Surg Oncol – volume: 43 start-page: 1741 issue: 7 year: 2019 end-page: 1747 article-title: Survival analysis of elderly patients with osteosarcoma publication-title: Int Orthop – volume: 140 start-page: 883 issue: 6 year: 2010 end-page: 899 article-title: Immunity, inflammation, and cancer publication-title: Cell – volume: 193 start-page: 289 issue: 1 year: 2015 end-page: 294 article-title: Metastasis‐promoting role of extravasated platelet activation in tumor publication-title: J Surg Res – volume: 4 start-page: 83 issue: 2 year: 2016 end-page: 91 article-title: The complex role of neutrophils in tumor angiogenesis and metastasis publication-title: Cancer Immunol Res – volume: 9 start-page: 237 issue: 2 year: 2011 end-page: 249 article-title: The platelet contribution to cancer progression publication-title: J Thromb Haemost – volume: 9 start-page: S51 issue: Suppl 2 year: 2005 end-page: S63 article-title: The causes and consequences of cancer‐associated malnutrition publication-title: Eur J Oncol Nurs – volume: 152 start-page: 259 issue: 2 year: 2019 end-page: 264 article-title: Systemic immune‐inflammation index predicts prognosis in patients with epithelial ovarian cancer: a retrospective study publication-title: Gynecol Oncol – volume: 33 start-page: 949 issue: 5 year: 2012 end-page: 955 article-title: Tumor‐associated neutrophils: friend or foe? publication-title: Carcinogenesis – volume: 13 start-page: 759 issue: 11 year: 2013 end-page: 771 article-title: Inflammation‐induced cancer: crosstalk between tumours, immune cells and microorganisms publication-title: Nat Rev Cancer – volume: 17 start-page: 432 issue: 6 year: 2004 end-page: 437 article-title: Serum albumin: relationship to inflammation and nutrition publication-title: Sem Dialysis – volume: 271 start-page: 693 issue: 4 year: 2020 end-page: 700 article-title: Prognostic nutritional index, tumor‐infiltrating lymphocytes, and prognosis in patients with esophageal cancer publication-title: Ann Surg – volume: 29 start-page: iv79 issue: Suppl 4 year: 2018 end-page: iv95 article-title: Bone sarcomas: ESMO‐PaedCan‐EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow‐up publication-title: Ann Oncol – volume: 33 start-page: 3029 issue: 27 year: 2015 end-page: 3035 article-title: Osteosarcoma: current treatment and a collaborative pathway to success publication-title: J Clin Oncol – volume: 198 start-page: 405 issue: 2 year: 2020 end-page: 414 article-title: High systemic Immune‐Inflammation Index (SII) represents an unfavorable prognostic factor for small cell lung cancer treated with etoposide and platinum‐based chemotherapy publication-title: Lung – ident: e_1_2_11_9_1 doi: 10.1007/s00264-019-04332-y – ident: e_1_2_11_3_1 doi: 10.1038/nrendo.2017.16 – volume: 5 start-page: 678 year: 2014 ident: e_1_2_11_30_1 article-title: Platelets in inflammation: regulation of leukocyte activities and vascular repair publication-title: Front Immunol – ident: e_1_2_11_41_1 doi: 10.1016/j.ejon.2005.09.007 – ident: e_1_2_11_28_1 doi: 10.1007/s11605-020-04710-7 – ident: e_1_2_11_22_1 doi: 10.1016/j.ygyno.2018.11.034 – ident: e_1_2_11_33_1 doi: 10.1111/j.1538-7836.2010.04131.x – ident: e_1_2_11_12_1 doi: 10.1016/j.cell.2010.01.025 – ident: e_1_2_11_24_1 doi: 10.1002/jcp.27052 – ident: e_1_2_11_7_1 doi: 10.1093/annonc/mdy310 – ident: e_1_2_11_37_1 doi: 10.1038/nri3174 – ident: e_1_2_11_20_1 doi: 10.1016/j.lungcan.2017.07.024 – ident: e_1_2_11_13_1 doi: 10.1097/MCO.0b013e32832a7902 – ident: e_1_2_11_25_1 doi: 10.1111/crj.12925 – ident: e_1_2_11_14_1 doi: 10.1146/annurev-nutr-121415-112634 – ident: e_1_2_11_40_1 doi: 10.1111/j.0894-0959.2004.17603.x – ident: e_1_2_11_35_1 doi: 10.1158/2326-6066.CIR-15-0313 – ident: e_1_2_11_18_1 doi: 10.1186/s12967-018-1638-9 – ident: e_1_2_11_6_1 doi: 10.1007/s10552-015-0607-3 – ident: e_1_2_11_10_1 doi: 10.1016/j.ejso.2016.04.056 – ident: e_1_2_11_17_1 doi: 10.1038/nrclinonc.2012.209 – ident: e_1_2_11_26_1 doi: 10.1007/s00408-020-00333-6 – ident: e_1_2_11_11_1 doi: 10.1200/JCO.19.00827 – ident: e_1_2_11_19_1 doi: 10.1016/j.ejso.2019.10.024 – ident: e_1_2_11_38_1 doi: 10.1038/nrc3611 – ident: e_1_2_11_29_1 doi: 10.1007/s10555-017-9673-1 – ident: e_1_2_11_2_1 doi: 10.1200/JCO.2017.75.1743 – ident: e_1_2_11_16_1 doi: 10.1038/nrclinonc.2016.24 – ident: e_1_2_11_4_1 doi: 10.1245/s10434-013-3210-4 – ident: e_1_2_11_5_1 doi: 10.1186/s10195-020-00552-w – ident: e_1_2_11_15_1 doi: 10.1016/S1470-2045(14)70263-3 – ident: e_1_2_11_32_1 doi: 10.1016/j.jss.2014.07.037 – ident: e_1_2_11_23_1 doi: 10.21037/apm.2020.04.31 – ident: e_1_2_11_21_1 doi: 10.1097/SLA.0000000000002985 – ident: e_1_2_11_34_1 doi: 10.1038/sj.bjp.0706013 – ident: e_1_2_11_8_1 doi: 10.1200/JCO.2014.59.4895 – ident: e_1_2_11_36_1 doi: 10.1093/carcin/bgs123 – ident: e_1_2_11_39_1 doi: 10.1016/j.lungcan.2017.07.003 – ident: e_1_2_11_31_1 doi: 10.1186/s13045-018-0669-2 – ident: e_1_2_11_27_1 doi: 10.1002/jcp.28476 |
SSID | ssj0009964 |
Score | 2.4217389 |
Snippet | Objective
This retrospective study of patients with osteosarcoma investigated the following biomarkers of inflammation and nutritional status:... This retrospective study of patients with osteosarcoma investigated the following biomarkers of inflammation and nutritional status: neutrophil-to-lymphocyte... ObjectiveThis retrospective study of patients with osteosarcoma investigated the following biomarkers of inflammation and nutritional status:... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 754 |
SubjectTerms | Adolescent Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers Biomarkers, Tumor - analysis Blood Platelets - pathology Bone cancer Bone Neoplasms - drug therapy Bone Neoplasms - immunology Bone Neoplasms - mortality Bone Neoplasms - pathology Female Follow-Up Studies Humans Inflammation Inflammation - drug therapy Inflammation - immunology Inflammation - mortality Inflammation - pathology Lymphatic Metastasis Lymphocytes - pathology Male Medical prognosis Middle Aged Neoadjuvant Therapy - mortality Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - immunology Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - pathology Neutrophils - pathology Nutrition Assessment Nutritional status osteosarcoma Osteosarcoma - drug therapy Osteosarcoma - immunology Osteosarcoma - mortality Osteosarcoma - secondary Preoperative Care Prognosis prognostic nutritional index Retrospective Studies ROC Curve Sarcoma Survival Rate systemic immune‐inflammation index Young Adult young and elderly |
Title | Preoperative prognostic nutritional index and systemic immune‐inflammation index predict survival outcomes in osteosarcoma: A comparison between young and elderly patients |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjso.26757 https://www.ncbi.nlm.nih.gov/pubmed/34811745 https://www.proquest.com/docview/2626826673 https://www.proquest.com/docview/2601485279 |
Volume | 125 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LTt0wEB0hFqibPujrFqjcqotucsl1bCfAClUghNSH2iKxqBTZjiO1QHJ1kyxg1U_gR_ipfkln7CQIaKWqu0iexE5yxnOczBwDvEmE5TxD_zaiUJGQCGMMQ2WEwcrKOCmVKX2C7Ad1cCQOj-XxEuwMtTBBH2L84Eae4edrcnBtms1r0dAfTT3lSHepkpxytYgQfb6WjkIeLwalcJFuxYOqUMw3xzNvxqI7BPMmX_UBZ_8BfBuGGvJMTqZda6b24paK43_ey0O43xNRthuQ8wiWXLUKK-_7X-2P4erTwtVzF4TBGaVxVTVpOrNq0O_Hs73WItNVwYIiNDZ_p4IT9-vnJUIX0RYqI3vD-YIu37KmwwkKIc7qrsWhugbbGVWb1A36XX2mt9kus-MOiaxPJmPnNDX57hxtLn56znpZ2OYJHO3vfX13EPV7O0Q2kUkaIaswStu0TAoS4Mm4nmE4VSYtuUtiXshMqYIbqXQ5i8uMO4XrupmwGlfUTtkseQrLVV2558C00QUvhTFSF6KInZakqodIy2JHdGgCb4e3nNte-Jz23zjNg2Qzz_Hx5_7xT-D1aDoPah9_MlofoJL3Dt9gC1e4UlNpMoFXYzO6Kv1_0ZWrO7Khz7eSp1sTeBYgNvZC9dC4OJQ4WA-Uv3efH3756A9e_LvpGtzj5Ag-d24dlttF5zaQTLXmpfea366LH7E |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIgEX3o-lBQwCiUu2Wcd2UiQOFaXaPkHQSr2lduJIQElWm0TVcuIn8EPoT-mf4Jcw4zyq8pC49MBtJc_G0Xiezsw3AE8DkXAeoX4bkSpPSBRjdEOZh84qkX6QKZO5AtkdNd4TG_tyfw6-d70wDT5Ef-FGmuHsNSk4XUgvnaKGfiyLIcd4N2xLKjft7AgTtvLl-iqe7jPO117vvhp77UwBLwlkEHrozYzSSZgFKQG_RFyP0IwrE2bcBj5PZaRUyo1UOhv5WcStwnxiJBKNmZxVSRTgcy_ARZogTkj9q-9OwaowcxAdNrkIl_0Ox8jnS_2rnvV-v4W0ZyNk5-LWrsFJx5ymsuXTsK7MMPnyC27k_8K963C1jbXZSqMcN2DO5jfh0nZbTXALjt9ObTGxDfY5o0q1vCDYapZ3Iwrw3w5Okuk8ZQ3oNS5_oJ4a--PrN9ROVKim-bMlnEzp8RUra7TBqMWsqCvkjS1xnVFDTVEiH4rP-gVbYUk_BJK19XJsRtbXbWdpfvrhjLXIt-Vt2DsXZt2B-bzI7T1g2uiUZ8IYqVOR-lZLAg5EZYp8SxHfAJ53YhUnLbY7jRg5jBtUah7jccfuuAfwpCedNIAmfyJa7GQzbm1aiStcYTKqwmAAj_tltEb0iUnntqiJhm6oJQ-XB3C3kel-F2r5xvxX4ss6yfz79vHG-zfux_1_J30El8e721vx1vrO5gJc4aSFrlRwEearaW0fYOxYmYdOZRkcnLeU_wS3MXqQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIlVcyhsWChgEEpdss47tZJE4VCyrPqBUQKXeUjtxpEJJVptEaDnxE_gfiH_Cr-CXMOM8qvKQuPTALZIncTSeZzLzDcDDQCScR6jfRqTKExLFGN1Q5qGzSqQfZMpkrkB2V23ui-0DebAEX7temAYfov_gRprh7DUp-CzN1k9AQ9-VxZBjuBu2FZU7dvER87Xy6dYED_cR59Pnb59teu1IAS8JZBB66MyM0kmYBSnhvkRcj9CKKxNm3AY-T2WkVMqNVDob-VnErcJ0YiQSjYmcVUkU4HPPwXmh_DHNiZi8PsGqwsRBdNDkIhz7HYyRz9f7Vz3t_H6LaE8HyM7DTS_C9443TWHL-2FdmWHy6RfYyP-EeZdgtY202UajGpdhyeZXYOVlW0twFb7tzW0xsw3yOaM6tbwg0GqWdwMK8G4HJsl0nrIG8hqXj6ijxv74_AV1E9Wpaf1sCWdzenzFyhotMOowK-oKWWNLXGfUTlOUyIfig37CNljSj4BkbbUcW5DtddtZmp5-vGAt7m15DfbPhFnXYTkvcnsTmDY65ZkwRupUpL7VkmADUZUi31K8N4DHnVTFSYvsTgNGjuMGk5rHeNyxO-4BPOhJZw2cyZ-I1jrRjFuLVuIKV5iKqjAYwP1-GW0R_WDSuS1qoqHv05KH4wHcaES634UavjH7lfiyTjD_vn28_eaVu7j176T3YGVvMo1fbO3u3IYLnHTQ1QmuwXI1r-0dDBwrc9cpLIPDsxbyn8G9eT8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preoperative+prognostic+nutritional+index+and+systemic+immune-inflammation+index+predict+survival+outcomes+in+osteosarcoma%3A+A+comparison+between+young+and+elderly+patients&rft.jtitle=Journal+of+surgical+oncology&rft.au=Ma%2C+Cong&rft.au=Yu%2C+Ronghui&rft.au=Li%2C+Junhong&rft.au=Guo%2C+Jingjing&rft.date=2022-03-01&rft.issn=1096-9098&rft.eissn=1096-9098&rft.volume=125&rft.issue=4&rft.spage=754&rft_id=info:doi/10.1002%2Fjso.26757&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-4790&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-4790&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-4790&client=summon |